- Home
- Publications
- Publication Search
- Publication Details
Title
Overview and Current Advances in Dapsone Hypersensitivity Syndrome
Authors
Keywords
-
Journal
CURRENT ALLERGY AND ASTHMA REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-07
DOI
10.1007/s11882-023-01109-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug-Induced Hypersensitivity Syndrome (DIHS)/ Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis
- (2022) Natsumi Hama et al. Journal of Allergy and Clinical Immunology-In Practice
- Implementation of genetic screening test to reduce the incidence of dapsone hypersensitivity syndrome among patients with leprosy in Papua, Indonesia: a study protocol
- (2022) Hana Krismawati et al. BMJ Open
- HLA Class-II‒Restricted CD8+ T Cells Contribute to the Promiscuous Immune Response in Dapsone-Hypersensitive Patients
- (2021) Qing Zhao et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Characterization of T-Cell Responses to SMX and SMX-NO in Co-Trimoxazole Hypersensitivity Patients Expressing HLA-B*13:01
- (2021) Jirawat Pratoomwun et al. Frontiers in Immunology
- HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients
- (2021) Patompong Satapornpong et al. Frontiers in Immunology
- Efficacy of add‐on therapy with intravenous immunoglobulin in steroid hyporesponsive DRESS syndrome
- (2021) Da Woon Sim et al. CTS-Clinical and Translational Science
- Is steroid pulse therapy a suitable treatment for drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan
- (2021) Hideo Hashizume et al. JOURNAL OF DERMATOLOGY
- Risk of Progression to Autoimmune Disease in Severe Drug Eruption: Risk Factors and the Factor-Guided Stratification
- (2021) Yoshiko Mizukawa et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genetic Variants Associated with T‐Cell Mediated Cutaneous Adverse Drug Reactions: A Prisma‐Compliant Systematic Review – an EAACI Position Paper
- (2020) Abderrahim Oussalah et al. ALLERGY
- Treatment for oral lesions in pediatric patients with Stevens‐Johnson's syndrome: A case report and literature review
- (2020) Natalia Barea‐Jiménez et al. International Journal of Paediatric Dentistry
- Evaluation of Cyclosporine for the Treatment of DRESS Syndrome
- (2020) Emily Nguyen et al. JAMA Dermatology
- A case of dapsone hypersensitivity syndrome in an Indian leprosy patient: Retrospective screening reveals the genetic connection with HLA‐B *13:01
- (2020) Janardhan Bommakanti et al. Dermatologic Therapy
- The HLA-B*13:01 and the dapsone hypersensitivity syndrome in Korean and Asian populations: genotype- and meta-analyses
- (2020) Hye Jung Park et al. Expert Opinion On Drug Safety
- Dynamic cytokine profiles combined with enzyme-linked immunospot assay are useful for immunologically confirming the dapsone hypersensitivity syndrome
- (2020) Jiabao You et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Validation study of HLA-B*13:01 as a biomarker of dapsone hypersensitivity syndrome in leprosy patients in Indonesia
- (2020) Hana Krismawati et al. PLoS Neglected Tropical Diseases
- Síndrome de hipersensibilidad a la dapsona de aparición tardía
- (2019) Lucía Ordieres Ortega et al. MEDICINA CLINICA
- Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy
- (2019) Hong Liu et al. JAMA Dermatology
- Case Report: A Case of Type 1 Leprosy Reaction and Dapsone Hypersensitivity Syndrome Complicating the Clinical Course of Multibacillary Leprosy
- (2019) Jeffrey Craig et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Dapsone- and nitroso dapsone-specific activation of T-cells from hypersensitive patients expressing the risk allele HLA-B*13:01
- (2019) Qing Zhao et al. ALLERGY
- HLA Screening for Dapsone Hypersensitivity in India—A Long Way Ahead—In Reply
- (2019) Hong Liu et al. JAMA Dermatology
- HLA Screening for Dapsone Hypersensitivity in India—A Long Way Ahead
- (2019) Anuradha Bishnoi et al. JAMA Dermatology
- Th17 Response of Borderline-Lepromatous Leprosy Inhibits Rash Manifestation of Dapsone Hypersensitivity Syndrome
- (2018) Tamara de Nardo Vanzela et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Dapsone-induced drug reaction with eosinophilia and systemic symptoms associated with HLA-B*13:01
- (2018) Fenfen Cai et al. INTERNAL MEDICINE JOURNAL
- Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions
- (2018) Chuang-Wei Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions
- (2018) Wei-Ti Chen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Amino Acid Variants of HLA-DRB1 Confer Susceptibility to Dapsone Hypersensitivity Syndrome in Addition to HLA-B*13:01
- (2018) Zhenhua Yue et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions
- (2018) Wimonchat Tangamornsuksan et al. JAMA Dermatology
- Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- (2018) Hideaki Watanabe Journal of Immunology Research
- HLA Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
- (2018) Nontaya Nakkam et al. Frontiers in Genetics
- Anatopic response: Double sparing phenomenon in a patient with dapsone hypersensitivity syndrome
- (2017) RaghuRam Maddala et al. Indian Journal of Dermatology Venereology & Leprology
- A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome
- (2017) Hideaki Watanabe et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13
- (2017) Therdpong Tempark et al. Pharmacogenetics and Genomics
- Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions
- (2016) Patricia T Illing et al. CURRENT OPINION IN IMMUNOLOGY
- Cutaneous rash and dapsone-induced hypersensitivity syndrome a common manifestation in adult immune thrombocytopenia. Presentation and outcome in 16 cases
- (2015) GaËtan Sauvetre et al. AMERICAN JOURNAL OF HEMATOLOGY
- Dapsone Hypersensitivity Syndrome-related Lung Injury without Eosinophilia in the Bronchoalveolar Lavage Fluid
- (2015) Yuhei Kinehara et al. INTERNAL MEDICINE
- Drug-induced acute pancreatitis: A rare manifestation of an incomplete "dapsone syndrome
- (2014) AnupK Das et al. INDIAN JOURNAL OF PHARMACOLOGY
- CCR10 regulates balanced maintenance and function of resident regulatory and effector T cells to promote immune homeostasis in the skin
- (2014) Mingcan Xia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: A case report
- (2014) Angelica Garcia et al. PEDIATRIC TRANSPLANTATION
- Association between HLA-B*1301 and Dapsone-Induced Hypersensitivity Reactions among Leprosy Patients in China
- (2013) Hongsheng Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- DRESS syndrome
- (2013) Zain Husain et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome
- (2013) F.-R. Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypersensitivity Reactions to Dapsone: A Systematic Review
- (2012) J Schmitt et al. ACTA DERMATO-VENEREOLOGICA
- High-dose Intravenous Immunoglobulin Monotherapy for Drug-induced Hypersensitivity Syndrome
- (2012) Y Kito et al. ACTA DERMATO-VENEREOLOGICA
- Dapsone Hypersensitivity Syndrome That Occurred during Treatment of Pediatric Patient with Erythema Elevatum Diutinum
- (2012) Gun-Wook Kim et al. Annals of Dermatology
- Poor Benefit/Risk Balance of Intravenous Immunoglobulins in DRESS
- (2012) Baptiste Janela ARCHIVES OF DERMATOLOGY
- Alternative Procedure to Allow Continuation of Dapsone Therapy despite Serious Adverse Reaction in a Case of Dapsone-Sensitive Erythema Elevatum Diutinum
- (2012) Julien Seneschal et al. DERMATOLOGY
- Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient
- (2011) L. Ceccarelli et al. INFECTION
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
- (2010) Takeshi Ozeki et al. HUMAN MOLECULAR GENETICS
- Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations
- (2010) F. F. Gonzalez-Galarza et al. NUCLEIC ACIDS RESEARCH
- Dapsone hypersensitivity syndrome with circulating 190-kDa and 230-kDa autoantibodies
- (2009) J. S. Chun et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndrome
- (2009) K. J. Zhu et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Dapsone hypersensitivity syndrome in non-leprosy patients: A retrospective study of its incidence in a tertiary referral center in Taiwan
- (2009) Yi-Shuan Sheen et al. JOURNAL OF DERMATOLOGICAL TREATMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started